MCK McKesson Corporation Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
23:44
Jul 01
Jim Cramer Host, Mad Money CNBC
Health insurers and drug distributors are undervalued.
Health insurers and drug distributors deserve to trade higher. Cardinal Health had a great quarter obscured by sector rotation, and CVS gains will be long-lasting.
MCK
HIGH
23:05
Jun 03
Bloomberg Newswire (@business)
A $2.25 billion leveraged loan for McKesson's medical-surgical unit priced on Wednesday ahead of its planned IPO.
MCK
00:44
Feb 07
Jim Cramer Host, Mad Money CNBC
Medical distributors and managed care are performing well. * McKesson (MCK) & Cardinal Health (CAH): "Classic drug middlemen." They are consistent winners; buy them anytime they dip. * CVS Health (CVS): The only health insurer to own. It is now the last real national drugstore chain (with Walgreens private and Rite Aid closed) and is undervalued as a managed care play.

About MCK Analyst Coverage

Buzzberg tracks MCK (McKesson Corporation) across 2 sources. 2 bullish vs 0 bearish calls from 2 analysts. Sentiment: predominantly bullish (67%). 3 total trade ideas tracked. Latest voices: Jim Cramer, Bloomberg.